Drug intelligence / Profile preview

Ellimans Universal Embrocation

Development stage: Unknown
Lead developer: Horlicks
Modality: Small Molecules
Administration: Topical, Intravaginal

Overview

Ellimans Universal Embrocation is a legacy topical pharmaceutical product primarily containing acetic acid as its active ingredient. Historically manufactured by Thornton & Ross, it is formulated as an embrocation (liniment) or jelly for external application. The product functions as a localized acidifying agent, which has been utilized for maintaining or restoring physiological vaginal pH (typically 4.0 to 5.0) and for its traditional use as a counter-irritant in the management of musculoskeletal aches and pains. As an older medicinal product, it is categorized as a small molecule topical treatment.

Brand names: EllimansEllimans Universal Embrocation

Beyond the preview

Go deeper on Ellimans Universal Embrocation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ellimans Universal Embrocation.

Explore the full profile